Effective Characterization of peptide therapeutics at each step of manufacturing is necessary to minimize lot-to-lot variation in product quality. Ensuring the quality and equivalence between generic and brand name peptide drug products raises a number of challenges and those challenges differ according to the type of peptide drug. To prove the pharmaceutical equivalence of such synthetic peptides with the innovator drugs (Synthetic or rDNA origin), it is required to have a thorough understanding of advanced analytical and bioanalytical tools. At Energon, we use scientific excellency of experienced team and hyphenated analytical tools to Characterize the product. We believe to be “An extension of your own laboratory”, help you in successful ANDA submission and product commercialization.